Showing results (21-30 of 472) with videos related to

Sort By:
Pageof 48
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2013
The uncoupling of monocyte-platelet interactions from the induction of proinflammatory signaling in monocytesJillian Stephen, Barry Emerson, Keith A A Fox, et al.
Heart, Lung & Circulation|April 10, 2007
Bleeding events with antithrombotic therapy in patients with unstable angina or non-ST-segment elevation myocardial infarction; insights from a large clinical practice registry (GRACE)Martin K Stiles, Omar H Dabbous, Keith A A Fox, et al.
Inhalation Toxicology|January 6, 2010
Exposure to nitrogen dioxide is not associated with vascular dysfunction in manJeremy P Langrish, Magnus Lundbäck, Stefan Barath, et al.
The American Journal of Cardiology|September 5, 2002
Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary interventionKeith A A Fox, Elliott M Antman, Marc Cohen, et al.
JRSM Cardiovascular Disease|November 1, 2013
Anticoagulation in atrial fibrillation: the present and the futureMarc R Dweck, Anoop S V Shah, Keith A A Fox
American Heart Journal|December 24, 2003
Change in circulating cytokines after 2 forms of exercise training in chronic stable heart failureJohn P LeMaitre, Stuart Harris, Keith A A Fox, et al.
Journal of the American College of Cardiology|January 22, 2003
Acute systemic inflammation enhances endothelium-dependent tissue plasminogen activator release in menStanley Chia, Christopher A Ludlam, Keith A A Fox, et al.
Coronary Artery Disease|April 19, 2003
Evaluation of vascular injury following percutaneous transluminal coronary angioplasty: a comparison of the accuracy of two- and three-dimensional intracoronary ultrasound imagingNicholas D Palmer, Alistair Lessells, David B Northridge, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 8, 2011
Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of non-ST-segment elevation acute coronary syndromesMatthias Schwenkglenks, John E Brazier, Thomas D Szucs, et al.
Journal of Clinical Medicine|April 13, 2024
The Net Clinical Outcome of Dual-Pathway Inhibition in Clinical Practice: The "Xarelto plus Acetylsalicylic Acid: Treatment Patterns and Outcomes in Patients with Atherosclerosis" RegistryAlexander Breitenstein, Alain Gay, Kai Vogtländer, et al.
Pageof 48